Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Squamous Non-small Cell Lung Cancer × tremelimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignancies 1 Neoplasms 1 Lung Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Rare Tumours 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03319316 2022-01-10

SOLUTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡